Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
20 June 2023Website:
http://www.fortrea.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 17:13:16 GMTDividend
Analysts recommendations
Institutional Ownership
FTRE Latest News
DURHAM, N.C., June 19, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chief Financial Officer Jill McConnell will participate in a virtual fireside chat hosted by Elizabeth Anderson, senior managing director at Evercore ISI, to discuss Fortrea's business on Thursday, June 20, 2024 at 2:00 pm ET.
DURHAM, N.C., June 04, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access (“FPA”) businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building market-leading, technology-rich healthcare and industrial growth companies.
DURHAM, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 am ET.
Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials
Fortrea (Nasdaq: FTRE) announced today that Machelle Sanders has been appointed to the Company's Board of Directors. Ms. Sanders, who has over 30 years of experience in pharmaceutical and biotechnology companies, currently serves as North Carolina's Secretary of Commerce.
Fortrea Holdings Inc. (NASDAQ:FTRE) Q1 2024 Earnings Conference Call on May 13, 2024 at 8:00 AM ET featuring Tom Pike as Chairman and CEO, Jill McConnell as CFO, and Hima Inguva as Head of Investor Relations and Corporate Development. Conference call participants include analysts from Jefferies, Evercore, Citi, Baird, William Blair, Bank of America, and JP Morgan. Operator begins the call by welcoming attendees to the Fortrea first quarter 2024 earnings conference call.
Fortrea (Nasdaq: FTRE), a top contract research organization (CRO), has postponed the release of its first quarter 2024 financial results due to accounting and discontinued operations issues related to the recent agreement to sell assets from the Enabling Services segment.
Fortrea, a top global contract research organization, revealed that it will announce its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. A conference call will be held at 9:00 am ET that day to discuss the results and answer questions.
Fortrea Holdings Inc. (NASDAQ:FTRE ) Q4 2023 Earnings Conference Call March 11, 2024 9:00 AM ET Company Participants Hima Inguva - Head of Investor Relations and Corporate Development Tom Pike - Chief Executive Officer Jill McConnell - Chief Financial Officer Conference Call Participants David Windley - Jefferies Elizabeth Anderson - Evercore Max Smock - William Blair Justin Bowers - DB Patrick Donnelly - Citi Derik De Bruin - Bank of America Operator Ladies and gentlemen, thank you for standing by. Welcome to Fortrea Fourth Quarter 2023 Earnings Conference Call.
The contract healthcare research specialist posted quarterly earnings Monday morning. It handily beat analyst expectations on both the top and bottom lines.
What type of business is Fortrea Holdings?
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
What sector is Fortrea Holdings in?
Fortrea Holdings is in the Healthcare sector
What industry is Fortrea Holdings in?
Fortrea Holdings is in the Biotechnology industry
What country is Fortrea Holdings from?
Fortrea Holdings is headquartered in United States
When did Fortrea Holdings go public?
Fortrea Holdings initial public offering (IPO) was on 20 June 2023
What is Fortrea Holdings website?
https://www.fortrea.com
Is Fortrea Holdings in the S&P 500?
No, Fortrea Holdings is not included in the S&P 500 index
Is Fortrea Holdings in the NASDAQ 100?
No, Fortrea Holdings is not included in the NASDAQ 100 index
Is Fortrea Holdings in the Dow Jones?
No, Fortrea Holdings is not included in the Dow Jones index
When does Fortrea Holdings report earnings?
The next expected earnings date for Fortrea Holdings is 14 August 2024